Literature DB >> 6354151

Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.

S L Hauser, D M Dawson, J R Lehrich, M F Beal, S V Kevy, H L Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6354151     DOI： 10.1001/archneur.1983.04050100027009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

Review 1.  Cyclophosphamide for multiple sclerosis.

Authors:  L La Mantia; C Milanese; N Mascoli; R D'Amico; B Weinstock-Guttman
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Differentiating shunt-responsive normal pressure hydrocephalus from Alzheimer disease and normal aging: pilot study using automated MRI brain tissue segmentation.

Authors:  Yafell Serulle; Henry Rusinek; Ivan I Kirov; Hannah Milch; Els Fieremans; Alexander B Baxter; John McMenamy; Rajan Jain; Jeffrey Wisoff; James Golomb; Oded Gonen; Ajax E George
Journal:  J Neurol       Date:  2014-08-01       Impact factor: 4.849

3.  Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.

Authors:  Chitra Krishnan; Adam I Kaplin; Robert A Brodsky; Daniel B Drachman; Richard J Jones; Dzung L Pham; Nancy D Richert; Carlos A Pardo; David M Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C McArthur; Avindra Nath; Benjamin M Greenberg; Peter A Calabresi; Douglas A Kerr
Journal:  Arch Neurol       Date:  2008-06-09

4.  Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis.

Authors:  Mark Lipphardt; Manuel Wallbach; Michael J Koziolek
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.